Soroush Rais-Bahrami, MD

Soroush Rais-Bahrami, MD, provides a detailed examination of the timing and methodologies for post-ablation surveillance in prostate cancer care. His discussion emphasizes the critical importance of effective monitoring to ensure the success of ablative therapies and the early detection of any recurrence or progression of the disease.

Dr. Rais-Bahrami outlines the primary goals of post-ablation surveillance, including assessing treatment efficacy, identifying complications, and detecting residual or recurrent disease. He discusses various imaging modalities used in post-ablation surveillance, with multiparametric MRI (mpMRI) playing a central role. Dr. Rais-Bahrami also addresses the utility of PET-CT scans, particularly PSMA PET-CT. In addition to imaging, Dr. Rais-Bahrami highlights serum biomarkers, such as prostate-specific antigen (PSA), in surveillance protocols. He also discusses the timing of surveillance to ensure the detection of any issues and allow for prompt intervention.